PDSB · Categories · Form 4

PDSB - SEC Form 4 insider transactions

PDS Biotechnology Corporation (PDSB) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for PDSB

• 98d
  SEC Form 4 filed by Director Glover Stephen C.

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 98d
  SEC Form 4 filed by President/CEO Bedu-Addo Frank

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 98d
  SEC Form 4 filed by Chief Financial Officer Boesgaard Lars

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 98d
  SEC Form 4 filed by Chief Scientific Officer Conn Gregory

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 98d
  SEC Form 4 filed by Chief Operating Officer Toutain Stephan

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 98d
  SEC Form 4 filed by Chief Medical Officer Shepard Kirk V.

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 98d
  SEC Form 4 filed by Director Freitag Gregory Gene

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 98d
  SEC Form 4 filed by Senior VP, General Counsel Brown Spencer D.

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 98d
  SEC Form 4 filed by Director Ali-Jackson Kamil

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 98d
  SEC Form 4 filed by Director Iliev Ilian

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 98d
  SEC Form 4 filed by Director Brawley Otis W

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 319d
  SEC Form 4 filed by Chief Financial Officer Boesgaard Lars

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 319d
  SEC Form 4 filed by Chief Scientific Officer Conn Gregory

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 319d
  SEC Form 4 filed by Chief Operations Officer Toutain Stephan

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 319d
  SEC Form 4 filed by President/CEO Bedu-Addo Frank

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 319d
  SEC Form 4 filed by Chief Medical Officer Shepard Kirk V.

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 319d
  SEC Form 4 filed by Senior VP, General Counsel Brown Spencer D.

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 363d
  SEC Form 4 filed by Director Iliev Ilian

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 363d
  SEC Form 4 filed by Director Freitag Gregory Gene

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 363d
  SEC Form 4 filed by Director Brawley Otis W

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 363d
  SEC Form 4 filed by Director Ali-Jackson Kamil

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 363d
  SEC Form 4 filed by Director Glover Stephen C.

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 714d
  SEC Form 4 filed by Director Freitag Gregory Gene

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 714d
  SEC Form 4 filed by Director Brawley Otis W

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 714d
  SEC Form 4 filed by Director Ali-Jackson Kamil

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 714d
  SEC Form 4 filed by Director Glover Stephen C.

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 714d
  SEC Form 4 filed by Director Iliev Ilian

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 714d
  SEC Form 4 filed by Director Sykes Richard

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 768d
  SEC Form 4 filed by Toutain Stephan

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 868d
  SEC Form 4 filed by Shepard Kirk V.

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 918d
  SEC Form 4 filed by Boesgaard Lars

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1058d
  SEC Form 4 filed by Freitag Gregory Gene

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1058d
  SEC Form 4 filed by Brawley Otis W

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1058d
  SEC Form 4 filed by Ali-Jackson Kamil

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1058d
  SEC Form 4 filed by Sykes Richard

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1058d
  SEC Form 4 filed by Glover Stephen C.

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1058d
  SEC Form 4 filed by Iliev Ilian

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1250d
  SEC Form 4 filed by Wood Lauren

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1250d
  SEC Form 4 filed by Bedu-Addo Frank

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1250d
  SEC Form 4 filed by Conn Gregory

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1250d
  SEC Form 4 filed by Hill Matthew C

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1250d
  SEC Form 4 filed by Brown Spencer D.

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1285d
  SEC Form 4: Bedu-Addo Frank exercised 219,535 shares at a strike of $6.57 and covered exercise/tax liability with 175,184 shares, increasing direct ownership by 7% to 690,866 units

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1441d
  SEC Form 4 filed by Glover Steve C

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1441d
  SEC Form 4 filed by Iliev Ilian

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1441d
  SEC Form 4 filed by Brawley Otis W

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1441d
  SEC Form 4 filed by Freitag Gregory Gene

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1441d
  SEC Form 4 filed by Ali-Jackson Kamil

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1441d
  SEC Form 4 filed by Sykes Richard

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1467d
  SEC Form 4 filed by Brown Spencer D.

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1601d
  SEC Form 4 filed by Bedu-Addo Frank

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1601d
  SEC Form 4 filed by Wood Lauren

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1601d
  SEC Form 4 filed by Conn Gregory

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1638d
  SEC Form 4: Hill Matthew C bought $27,860 worth of shares (3,100 units at $8.99), increasing direct ownership by 297% to 3,875 units

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1693d
  SEC Form 4 filed by Hill Matthew C

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1814d
  SEC Form 4: Bloomquist DeLyle W exercised 2,970 units of Common Stock at a strike of $5.99 and bought $98,778 worth of Common Stock (10,000 units at $9.88), increasing direct ownership by 7% to 193,888 units

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1818d
  SEC Form 4: BEDU-ADDO FRANK exercised 53,174 units of Common Stock at a strike of $6.57 and covered exercise/tax liability with 27,166 units of Common Stock, increasing direct ownership by 4% to 646,515 units

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1818d
  SEC Form 4 filed by BRAWLEY OTIS W

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1818d
  SEC Form 4: Glover Steve C bought $49,997 worth of Common Stock (5,882 units at $8.50), increasing direct ownership by 10% to 63,790 units

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1818d
  SEC Form 4: Ali-Jackson Kamil bought $99,994 worth of Common Stock (11,764 units at $8.50)

  4 - PDS Biotechnology Corp (0001472091) (Issuer)

Other PDSB categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends